8-(3-carboxy-1-methylpropylamino)-6-methoxyquinoline has been researched along with chloroquine in 2 studies
| Studies (8-(3-carboxy-1-methylpropylamino)-6-methoxyquinoline) | Trials (8-(3-carboxy-1-methylpropylamino)-6-methoxyquinoline) | Recent Studies (post-2010) (8-(3-carboxy-1-methylpropylamino)-6-methoxyquinoline) | Studies (chloroquine) | Trials (chloroquine) | Recent Studies (post-2010) (chloroquine) |
|---|---|---|---|---|---|
| 26 | 3 | 12 | 16,405 | 763 | 4,029 |
| Protein | Taxonomy | 8-(3-carboxy-1-methylpropylamino)-6-methoxyquinoline (IC50) | chloroquine (IC50) |
|---|---|---|---|
| glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | Plasmodium berghei | 43 | |
| Spike glycoprotein | Betacoronavirus England 1 | 5.47 | |
| Replicase polyprotein 1ab | Betacoronavirus England 1 | 5.47 | |
| Transmembrane protease serine 2 | Homo sapiens (human) | 5.47 | |
| Dihydrofolate reductase | Bos taurus (cattle) | 0.0301 | |
| Amyloid-beta precursor protein | Homo sapiens (human) | 7 | |
| Histidine-rich protein PFHRP-II | Plasmodium falciparum (malaria parasite P. falciparum) | 0.2383 | |
| Procathepsin L | Homo sapiens (human) | 5.47 | |
| Replicase polyprotein 1a | Severe acute respiratory syndrome-related coronavirus | 5.47 | |
| Replicase polyprotein 1ab | Human coronavirus 229E | 5.47 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | 5.47 | |
| Spike glycoprotein | Severe acute respiratory syndrome coronavirus 2 | 3.58 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 6.375 | |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | Homo sapiens (human) | 1.5 | |
| Serine/threonine-protein kinase mTOR | Homo sapiens (human) | 0.27 | |
| Beta-secretase 1 | Homo sapiens (human) | 7 | |
| Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | 5.47 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 2.503 | |
| Angiotensin-converting enzyme 2 | Homo sapiens (human) | 6.235 | |
| Cysteine proteinase falcipain 2a | Plasmodium falciparum (malaria parasite P. falciparum) | 0.02 | |
| Cysteine proteinase falcipain 2a | Plasmodium falciparum (malaria parasite P. falciparum) | 0.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ashley, EA; Charunwatthana, P; Day, NP; Hanboonkunupakarn, B; Hanpithakpong, W; Jittamala, P; Lawpoolsri, S; Lee, SJ; Pukrittayakamee, S; Tarning, J; White, NJ | 1 |
| Aung, AA; Blessborn, D; Chu, CS; Hanpithakpong, W; Imwong, M; Kraft, K; Ling, C; Nosten, FH; Phyo, AP; Proux, S; Soe, NL; Tarning, J; Thinraow, S; Watson, JA; White, NJ; Wilaisrisak, P; Win, HH; Yotyingaphiram, W | 1 |
2 trial(s) available for 8-(3-carboxy-1-methylpropylamino)-6-methoxyquinoline and chloroquine
| Article | Year |
|---|---|
Pharmacokinetic interactions between primaquine and chloroquine.
Topics: Adult; Antimalarials; Chloroquine; Cross-Over Studies; Drug Therapy, Combination; Female; Humans; Malaria; Malaria, Vivax; Male; Middle Aged; Plasmodium vivax; Primaquine; Young Adult | 2014 |
Determinants of Primaquine and Carboxyprimaquine Exposures in Children and Adults with Plasmodium vivax Malaria.
Topics: Adult; Antimalarials; Child; Child, Preschool; Chloroquine; Humans; Malaria, Vivax; Primaquine | 2021 |